TrianglePUBLICATIONS · 21766293
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2012 Feb 1
- First author
- Cooper TM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Cooper TM
- type
- Author
- name
- Franklin J
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Hurwitz C
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch B
- type
- Author
- name
- Smith FO
- type
- Author
- name
- Mathew P
- type
- Author
- name
- Arceci RJ
- type
- Author
- name
- Feusner J
- type
- Author
- name
- Iannone R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cooper TM
- type
- Author
- name
- Franklin J
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Hurwitz C
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch B
- type
- Author
- name
- Smith FO
- type
- Author
- name
- Mathew P
- type
- Author
- name
- Arceci RJ
- type
- Author
- name
- Feusner J
- type
- Author
- name
- Iannone R
- type
- Author
- bibliography ids
- nci-bib-126e77cf5f26df75a6bfeb0d
- book metadata
- content sha256
- 14612eae650cdf5f3e8c34dd59d8511ce5a0d3b04c3b2ad2bd1db08b9b0ed1e5
- document type
- citation
- dois
- 10.1002/cncr.26190
- electronic publication date
- display
- 2011 Jul 15
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21766293
- immutable id
- pubmed:21766293@14612eae650cdf5f3e8c34dd59d8511ce5a0d3b04c3b2ad2bd1db08b9b0ed1e5
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 3
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 761-9
- volume
- 118
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21766293
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- f66859c6da88a79713eadc2cb4b0b8ff7592711ef5d6c67d5a37182ab2230039
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2012 Feb 1
- precision
- day
- year
- 2012
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Preserved source evidence · Not medical advice